Hostname: page-component-68945f75b7-6rp8b Total loading time: 0 Render date: 2024-09-02T20:31:37.742Z Has data issue: false hasContentIssue false
  • English
  • Français

Neuroendocrine markers of high risk for psychosis: salivary testosterone in adolescent boys with prodromal symptoms

Published online by Cambridge University Press:  21 January 2011

S. van Rijn ,
A. Aleman ,
L. de Sonneville ,
M. Sprong ,
T. Ziermans ,
P. Schothorst ,
H. van Engeland  and
H. Swaab
S. van Rijn*
Affiliation:
Leiden University, Clinical Child and Adolescent Studies, Leiden, The Netherlands Leiden Institute for Brain and Cognition, Leiden, The Netherlands
A. Aleman
Affiliation:
University of Groningen, BCN NeuroImaging Center, Groningen, The Netherlands
L. de Sonneville
Affiliation:
Leiden University, Clinical Child and Adolescent Studies, Leiden, The Netherlands Leiden Institute for Brain and Cognition, Leiden, The Netherlands
M. Sprong
Affiliation:
University Medical Center Utrecht, Rudolf Magnus Institute of Neuroscience, Department of Psychiatry, Utrecht, The Netherlands
T. Ziermans
Affiliation:
University Medical Center Utrecht, Rudolf Magnus Institute of Neuroscience, Department of Psychiatry, Utrecht, The Netherlands
P. Schothorst
Affiliation:
University Medical Center Utrecht, Rudolf Magnus Institute of Neuroscience, Department of Psychiatry, Utrecht, The Netherlands
H. van Engeland
Affiliation:
University Medical Center Utrecht, Rudolf Magnus Institute of Neuroscience, Department of Psychiatry, Utrecht, The Netherlands
H. Swaab
Affiliation:
Leiden University, Clinical Child and Adolescent Studies, Leiden, The Netherlands Leiden Institute for Brain and Cognition, Leiden, The Netherlands
*
*Address for correspondence: S. van Rijn, Ph.D., Leiden University, Faculty of Social and Behavioural Sciences, Clinical Child and Adolescent Studies, Wassenaarseweg 52, 2333 AK Leiden, The Netherlands. (Email: srijn@fsw.leidenuniv.nl)
Get access Rights & Permissions [Opens in a new window]

Abstract

Background

The peak in age of onset of psychotic disorders such as schizophrenia during puberty and early adulthood suggests a relationship between the expression of psychopathology and the changes in the brain and body that take place during this dynamic maturational period, including a dramatic increase in circulating oestrogens and androgens. This study examined levels of salivary testosterone and oestradiol in adolescents with prepsychotic, prodromal symptoms, as this may mediate risk for psychosis by having an impact on brain development.

Method

In 21 male adolescents with prodromal symptoms and 21 male non-clinical controls levels of testosterone and oestradiol were measured in saliva. Tanner pubertal stage and prodromal symptoms were also assessed.

Results

Levels of testosterone were significantly lower in adolescents with prodromal symptoms as compared with non-clinical controls. No group differences in oestradiol were found. In the total sample, level of testosterone was significantly correlated with age and Tanner pubertal stage.

Conclusions

Our observations are in line with current hypotheses stressing the role of neuroendocrine factors during adolescence in the expression of psychotic symptoms. From a developmental perspective, susceptibility to psychotic disorders increases during adolescence. Our data suggest that testosterone might, in part, mediate this increased vulnerability. Further research is needed to assess the mediating, neural, mechanisms through which testosterone may have an impact on the development of psychotic symptoms. In the search for early risk markers for psychosis, studying neuroendocrine factors might increase our understanding of ‘at-risk’ developmental pathways.

Keywords

Adolescencehigh riskhormonesschizophreniatestosterone
Type
Original Articles
Information
Psychological Medicine , Volume 41 , Issue 9 , September 2011 , pp. 1815 - 1822
Copyright
Copyright © Cambridge University Press 2011

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Akhondzadeh, S, Rezaei, F, Larijani, B, Nejatisafa, AA, Kashani, L, Abbasi, SH (2006). Correlation between testosterone, gonadotropins and prolactin and severity of negative symptoms in male patients with chronic schizophrenia. Schizophrenia Research 84, 405–410.CrossRefGoogle ScholarPubMed
Arató, M, Frecska, E, Beck, C, An, M, Kiss, H (2004). Digit length pattern in schizophrenia suggests disturbed prenatal hemispheric lateralization. Progress in Neuro-Psychopharmacology and Biological Psychiatry 28, 191–194.Google Scholar
Bialek, M, Zaremba, P, Borowicz, KK, Czuczwar, SJ (2004). Neuroprotective role of testosterone in the nervous system. Polish Journal of Pharmacology 56, 509–518.Google ScholarPubMed
Ceskova, E, Prikryl, R, Kasparek, T (2007). Testosterone in first-episode schizophrenia. Neuroendocrinology Letters 28, 811–814.Google Scholar
Coleman, L, Coleman, J (2002). The measurement of puberty: a review. Journal of Adolescence 25, 535–550.Google Scholar
Collinson, SL, Lim, M, Chaw, JH, Verma, S, Sim, K, Rapisarda, A, Chong, SA (2010). Increased ratio of 2nd to 4th digit (2D:4D) in schizophrenia. Psychiatry Research 176, 8–12.CrossRefGoogle Scholar
Correll, CU, Hauser, M, Auther, AM, Cornblatt, BA (2010). Research in people with psychosis risk syndrome: a review of the current evidence and future directions. Journal of Child Psychology and Psychiatry 51, 390–431.CrossRefGoogle ScholarPubMed
Dunn, JF, Nisula, BC, Rodbard, D (1981). Transport of steroid hormones – binding of 21 endogenous steroids to both testosterone-binding globulin and corticosteroid-binding globulin in human plasma. Journal of Clinical Endocrinology and Metabolism 53, 58–68.CrossRefGoogle ScholarPubMed
Goyal, RO, Sagar, R, Ammini, AC, Khurana, ML, Alias, AG (2004). Negative correlation between negative symptoms of schizophrenia and testosterone levels. Annals of the New York Academy of Sciences 1032, 291–294.CrossRefGoogle ScholarPubMed
Häfner, H, an der Heiden, W, Behrens, S, Gattaz, WF, Hambrecht, M, Löffler, W, Maurer, K, Munk Jørgensen, P, Nowotny, B, Riecher-Rössler, A, Stein, A (1998). Causes and consequences of the gender difference in age at onset of schizophrenia. Schizophrenia Bulletin 24, 99–113.CrossRefGoogle ScholarPubMed
Häfner, H, Behrens, S, De Vry, J, Gattaz, WF (1991). An animal model for the effects of estradiol on dopamine-mediated behavior: implications for sex differences in schizophrenia. Psychiatry Research 38, 125–134.CrossRefGoogle ScholarPubMed
Häfner, H, Riecher-Rössler, A, Anderheiden, W, Maurer, K, Fätkenheuer, B, Löffler, W (1993). Generating and testing a causal explanation of the gender difference in age at 1st onset of schizophrenia. Psychological Medicine 23, 925–940.Google Scholar
Huber, TJ, Tettenborn, C, Leifke, E, Emrich, HM (2005). Sex hormones in psychotic men. Psychoneuroendocrinology 30, 111–114.CrossRefGoogle ScholarPubMed
Kaneda, Y, Fujii, A (2000). Effects of chronic neuroleptic administration on the hypothalamo–pituitary–gonadal axis of male schizophrenics. Progress in Neuro-Psychopharmacology and Biological Psychiatry 24, 251–258.CrossRefGoogle ScholarPubMed
Keshavan, MS (1999). Development, disease and degeneration in schizophrenia: a unitary pathophysiological model. Journal of Psychiatric Research 33, 513–521.Google Scholar
Keshavan, MS, Hogarty, GE (1999). Brain maturational processes and delayed onset in schizophrenia. Development and Psychopathology 11, 525–543.CrossRefGoogle ScholarPubMed
Klosterkotter, J, Ruhrmann, S, Schultze-Lutter, F (2005). The European Prediction of Psychosis Study (EPOS): integrating early recognition and intervention in Europe. World Psychiatry 4, 161–167.Google ScholarPubMed
Ko, YH, Jung, SW, Joe, SH, Lee, CH, Jung, HG, Jung, IK, Kim, SH, Lee, MS (2007). Association between serum testosterone levels and the severity of negative symptoms in male patients with chronic schizophrenia. Psychoneuroendocrinology 32, 385–391.Google Scholar
Konarzewska, B, Wolczynski, S, Szulc, A, Galinska, B, Poplawska, R, Waszkiewicz, N (2009). Effect of risperidone and olanzapine on reproductive hormones, psychopathology and sexual functioning in male patients with schizophrenia. Psychoneuroendocrinology 34, 129–139.Google Scholar
Lutchmaya, S, Baron-Cohen, S, Raggatt, P, Knickmeyer, R, Manning, JT (2004). 2nd to 4th Digit ratios, fetal testosterone and estradiol. Early Human Development 77, 23–28.Google Scholar
McEwen, BS (1994). Steroid–hormone actions on the brain – when is the genome involved? Hormones and Behavior 28, 396–405.CrossRefGoogle ScholarPubMed
McGlashan, TH, Miller, TJ, Woods, SW, Rosen, JL, Hoffman, RE, Davidson, L (2001). Structured Interview for Prodromal Syndromes (SIPS), version 3.0. PRIME Research Clinic, Yale School of Medicine: New Haven, CT.Google Scholar
McGorry, PD, Killackey, E, Yung, A (2008). Early intervention in psychosis: concepts, evidence and future directions. World Psychiatry 7, 148–156.CrossRefGoogle ScholarPubMed
Miller, TJ, McGlashan, TH, Rosen, JL, Cadenhead, K, Ventura, J, McFarlane, W, Perkins, DO, Pearlson, GD, Woods, SW (2003). Prodromal assessment with the structured interview for prodromal syndromes and the scale of prodromal symptoms: predictive validity, interrater reliability, and training to reliability. Schizophrenia Bulletin 29, 703–715.CrossRefGoogle ScholarPubMed
Oades, RD (1994). Serum gonadal steroid hormones in young schizophrenic patients. Psychoneuroendocrinology 19, 373–385.Google Scholar
Ojeda, SR, Ma, YJ (1999). Glial–neuronal interactions in the neuroendocrine control of mammalian puberty: facilitatory effects of gonadal steroids. Journal of Neurobiology 40, 528–540.3.0.CO;2-V>CrossRefGoogle ScholarPubMed
Olsen, KA, Rosenbaum, B (2006). Prospective investigations of the prodromal state of schizophrenia: assessment instruments. Acta Psychiatrica Scandinavica 113, 273–282.Google Scholar
Peper, JS, Brouwer, RM, Schnack, HG, van Baal, GC, van Leeuwen, M, van den Berg, SM, Delemarre-Van de Waal, HA, Boomsma, DI, Kahn, RS, Hulshoff Pol, HE (2009). Sex steroids and brain structure in pubertal boys and girls. Psychoneuroendocrinology 34, 332–342.CrossRefGoogle ScholarPubMed
Rinieris, P, Hatzimanolis, J, Markianos, M, Stefanis, C (1989). Effects of treatment with various doses of haloperidol on the pituitary–gonadal axis in male-schizophrenic patients. Neuropsychobiology 22, 146–149.CrossRefGoogle ScholarPubMed
Romeo, RD (2003). Puberty: a period of both organizational and activational effects of steroid hormones on neurobehavioural development. Journal of Neuroendocrinology 15, 1185–1192.Google Scholar
Schultze-Lutter, F, Klosterkotter, J (2002). Bonn Scale for the Assessment of Basic Symptoms–Prediction List (BSABS-P). University of Cologne: Cologne.Google Scholar
Shirayama, Y, Hashimoto, K, Suzuki, Y, Higuchi, T (2002). Correlation of plasma neurosteroid levels to the severity of negative symptoms in male patients with schizophrenia. Schizophrenia Research 58, 69–74.Google Scholar
Sisk, CL, Zehr, JL (2005). Pubertal hormones organize the adolescent brain and behavior. Frontiers in Neuroendocrinology 26, 163–174.Google Scholar
Spear, LP (2000). The adolescent brain and age-related behavioral manifestations. Neuroscience and Biobehavioral Reviews 24, 417–463.CrossRefGoogle ScholarPubMed
Sprong, M, Becker, HE, Schothorst, PF, Swaab, H, Ziermans, TB, Dingemans, PM, Linszen, D, van Engeland, H (2008). Pathways to psychosis: a comparison of the pervasive developmental disorder subtype multiple complex developmental disorder and the ‘at risk mental state’. Schizophrenia Research 99, 38.Google Scholar
Stevens, JR (2002). Schizophrenia: reproductive hormones and the brain. American Journal of Psychiatry 159, 713–719.Google Scholar
Tanner, JM (1962). Growth at Adolescence. Blackwell Scientific Publications: Oxford.Google Scholar
Veldhuis, JD (1996). Neuroendocrine mechanisms mediating awakening of the human gonadotropic axis in puberty. Pediatric Nephrology (Berlin, Germany) 10, 304–317.CrossRefGoogle ScholarPubMed
Viau, V (2002). Functional cross-talk between the hypothalamic–pituitary–gonadal and – adrenal axes. Journal of Neuroendocrinology 14, 506–513.CrossRefGoogle ScholarPubMed
Walder, DJ, Andersson, TLC, McMillan, AL, Breedlove, SM, Walker, EF (2006). Sex differences in digit ratio (2D:4D) are disrupted in adolescents with schizotypal personality disorder: altered prenatal gonadal hormone levels as a risk factor. Schizophrenia Research 86, 118–122.Google Scholar
Walker, E, Bollini, AM (2002). Pubertal neurodevelopment and the emergence of psychotic symptoms. Schizophrenia Research 54, 17–23.Google Scholar
Wang, C, Plymate, S, Nieschlag, E, Paulsen, CA (1981). Salivary testosterone in men – further evidence of a direct correlation with free serum testosterone. Journal of Clinical Endocrinology and Metabolism 53, 1021–1024.CrossRefGoogle ScholarPubMed
Watson, CS, Gametchu, B (1999). Membrane-initiated steroid actions and the proteins that mediate them. Proceedings of the Society for Experimental Biology and Medicine 220, 9–19.Google Scholar